chrX-74591624-T-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_016120.4(RLIM):ā€‹c.1691A>Gā€‹(p.Asn564Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,210,326 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000080 ( 0 hom., 2 hem., cov: 24)
Exomes š‘“: 0.0000036 ( 0 hom. 2 hem. )

Consequence

RLIM
NM_016120.4 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.27
Variant links:
Genes affected
RLIM (HGNC:13429): (ring finger protein, LIM domain interacting) The protein encoded by this gene is a RING-H2 zinc finger protein. It has been shown to be an E3 ubiquitin protein ligase that targets LIM domain binding 1 (LDB1/CLIM), and causes proteasome-dependent degradation of LDB1. This protein and LDB1 are co-repressors of LHX1/LIM-1, a homeodomain transcription factor. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04265204).
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RLIMNM_016120.4 linkuse as main transcriptc.1691A>G p.Asn564Ser missense_variant 4/4 ENST00000332687.11
RLIMNM_183353.3 linkuse as main transcriptc.1691A>G p.Asn564Ser missense_variant 5/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RLIMENST00000332687.11 linkuse as main transcriptc.1691A>G p.Asn564Ser missense_variant 4/41 NM_016120.4 P1Q9NVW2-1
RLIMENST00000349225.2 linkuse as main transcriptc.1691A>G p.Asn564Ser missense_variant 5/52 P1Q9NVW2-1

Frequencies

GnomAD3 genomes
AF:
0.0000803
AC:
9
AN:
112116
Hom.:
0
Cov.:
24
AF XY:
0.0000584
AC XY:
2
AN XY:
34264
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000856
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000273
AC:
5
AN:
183405
Hom.:
0
AF XY:
0.0000589
AC XY:
4
AN XY:
67875
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.00000364
AC:
4
AN:
1098158
Hom.:
0
Cov.:
31
AF XY:
0.00000550
AC XY:
2
AN XY:
363518
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000114
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000802
AC:
9
AN:
112168
Hom.:
0
Cov.:
24
AF XY:
0.0000583
AC XY:
2
AN XY:
34326
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000855
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000144
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 18, 2021The c.1691A>G (p.N564S) alteration is located in exon 5 (coding exon 3) of the RLIM gene. This alteration results from a A to G substitution at nucleotide position 1691, causing the asparagine (N) at amino acid position 564 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
9.9
DANN
Benign
0.47
DEOGEN2
Benign
0.17
T;T
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.89
.;D
M_CAP
Benign
0.0069
T
MetaRNN
Benign
0.043
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-0.14
N;N
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.71
N;N
REVEL
Benign
0.14
Sift
Benign
0.39
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.043
B;B
Vest4
0.056
MutPred
0.28
Gain of catalytic residue at N564 (P = 0.0486);Gain of catalytic residue at N564 (P = 0.0486);
MVP
0.56
MPC
0.79
ClinPred
0.035
T
GERP RS
4.3
Varity_R
0.16
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs746510103; hg19: chrX-73811459; API